Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma
Status:
Not yet recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The study will assess if regular use of tiotropium (i.e. daily) results in loss of
bronchoprotection against methacholine induced bronchoconstriction in those with mild asthma.